zepp health - ZEPP

ZEPP

Close Chg Chg %
11.81 0.03 0.25%

Closed Market

11.84

+0.03 (0.25%)

Volume: 56.37K

Last Updated:

Apr 2, 2026, 3:58 PM EDT

Company Overview: zepp health - ZEPP

ZEPP Key Data

Open

$11.06

Day Range

10.84 - 11.90

52 Week Range

2.13 - 61.84

Market Cap

$83.74M

Shares Outstanding

7.04M

Public Float

7.04M

Beta

1.77

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.52

Yield

0.00%

Dividend

$0.08

EX-DIVIDEND DATE

Mar 25, 2022

SHORT INTEREST

N/A

AVERAGE VOLUME

108.08K

 

ZEPP Performance

1 Week
 
9.08%
 
1 Month
 
-34.24%
 
3 Months
 
-57.58%
 
1 Year
 
355.56%
 
5 Years
 
-74.04%
 

ZEPP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About zepp health - ZEPP

Zepp Health Corp. engages in the development of smart wearable health and consumer fitness devices. It empowers users to achieve their well-being goals by optimizing their health, fitness, and wellness journeys. Its brands include Amazfit, Zepp Clarity, and Zepp Aura. The company was founded by Huang Wang in 2013 and is headquartered in Gorinchem, Netherlands.

ZEPP At a Glance

Zepp Health Corp.
Edisonweg 44–B08
Gorinchem, Groningen 4207 HG
Phone 31-616-086-658 Revenue 259.58M
Industry Other Consumer Specialties Net Income -40,173,969.27
Sector Consumer Durables 2025 Sales Growth 42.085%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

ZEPP Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.65
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales 2.094
Total Debt to Enterprise Value 0.42

ZEPP Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 3.528
Total Asset Turnover 0.475

ZEPP Liquidity

Current Ratio 1.023
Quick Ratio 0.77
Cash Ratio 0.394

ZEPP Profitability

Gross Margin 39.205
Operating Margin -11.29
Pretax Margin -13.698
Net Margin -15.476
Return on Assets -7.348
Return on Equity -17.238
Return on Total Capital -9.078
Return on Invested Capital -13.304

ZEPP Capital Structure

Total Debt to Total Equity 106.291
Total Debt to Total Capital 51.525
Total Debt to Total Assets 40.371
Long-Term Debt to Equity 28.237
Long-Term Debt to Total Capital 13.688
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Zepp Health - ZEPP

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
615.24M 352.20M 182.69M 259.58M
Sales Growth
-36.51% -42.75% -48.13% +42.09%
Cost of Goods Sold (COGS) incl D&A
495.97M 259.36M 112.43M 157.81M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 8.71M 7.69M 5.02M
Depreciation
- 6.15M 5.19M 2.57M
Amortization of Intangibles
2.56M 2.49M 2.45M 2.32M
COGS Growth
-35.31% -47.71% -56.65% +40.37%
Gross Income
119.27M 92.84M 70.27M 101.77M
Gross Income Growth
-41.09% -22.16% -24.31% +44.83%
Gross Profit Margin
+19.39% +26.36% +38.46% +39.20%
2022 2023 2024 2025 5-year trend
SG&A Expense
180.19M 122.07M 117.54M 128.76M
Research & Development
76.80M 51.07M 46.18M 45.44M
Other SG&A
103.40M 71.00M 71.36M 83.32M
SGA Growth
-4.09% -32.25% -3.71% +9.54%
Other Operating Expense
- - - 2.32M
-
Unusual Expense
(5.64M) 143.12K 8.12M 2.12M
EBIT after Unusual Expense
(55.29M) (29.37M) (55.40M) (31.43M)
Non Operating Income/Expense
8.43M 2.69M 3.02M 1.59M
Non-Operating Interest Income
1.83M 3.20M 3.67M 1.53M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
8.47M 6.73M 5.55M 5.71M
Interest Expense Growth
+21.63% -20.46% -17.50% +2.83%
Gross Interest Expense
8.47M 6.73M 5.55M 5.71M
Interest Capitalized
- - - -
-
Pretax Income
(55.32M) (33.42M) (57.93M) (35.56M)
Pretax Income Growth
-434.49% +39.59% -73.35% +38.62%
Pretax Margin
-8.99% -9.49% -31.71% -13.70%
Income Tax
(9.78M) (2.23M) 13.70M 2.54M
Income Tax - Current - Domestic
- 56.28K 409.74K 248.12K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (9.84M) (2.64M) 13.45M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(42.92M) (30.00M) (75.85M) (40.17M)
Minority Interest Expense
- (102.91K) (65.63K) (75.04K)
Net Income
(42.82M) (29.94M) (75.77M) (40.17M)
Net Income Growth
-300.38% +30.08% -153.09% +46.98%
Net Margin Growth
-6.96% -8.50% -41.47% -15.48%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(42.82M) (29.94M) (75.77M) (40.17M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(42.82M) (29.94M) (75.77M) (40.17M)
EPS (Basic)
-2.7816 -1.9702 -4.6831 -2.5263
EPS (Basic) Growth
-305.18% +29.17% -137.70% +46.05%
Basic Shares Outstanding
15.39M 15.20M 16.18M 15.90M
EPS (Diluted)
-2.7816 -1.9702 -4.6831 -2.5263
EPS (Diluted) Growth
-315.09% +29.17% -137.70% +46.05%
Diluted Shares Outstanding
15.39M 15.20M 16.18M 15.90M
EBITDA
- (52.22M) (21.55M) (42.25M)
EBITDA Growth
- -330.94% +58.74% -96.11%
EBITDA Margin
- -8.49% -6.12% -23.13%

Snapshot

Average Recommendation BUY Average Target Price 64.37
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date N/A Current Year's Estimate N/A
Last Quarter’s Earnings -0.03 Median PE on CY Estimate N/A
Year Ago Earnings -0.12 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates N/A N/A N/A N/A
Mean Estimate N/A N/A N/A N/A
High Estimates N/A N/A N/A N/A
Low Estimate N/A N/A N/A N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Zepp Health in the News